Linyu Wu

Dr. Linyu Wu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
LWLinyu Wu
Linyu Wu
CGChen Gao
Chen Gao
PXPing Xiang
Ping Xiang
SZSisi Zheng
Sisi Zheng
PPPeipei Pang
Peipei Pang
MXMaosheng Xu
Maosheng Xu
Objective: To evaluate whether radiomic features extracted from intra and perinodular lesions can enhance the ability to differentiate between invasive lung adenocarcinoma (IA), minimally invasive adenocarcinoma (MIA) and adenocarcinoma in situ (AIS) manifesting as ground-glass nodules. Materials and Methods: This retrospective study included 120 patients with a total of 121 pathologically confirmed lung adenocarcinomas (85 IA and 36 AIS/MIA) between January 2015 to May 2019. Patients divided into training (n=84) and validation sets (n=37) randomly. The intranodular, perinodular, and gross region of interests (ROI) were delineated with manual annotation. Image features were quantitatively extracted from each ROI on CT images. The mRMR feature ranking method and LASSO classifier were used to eliminate usefulness features. A combined clinical-radiomic model was constructed by multivariable logistic regression analysis. The predicted performances of different models were evaluated using receiver operating curve (ROC) and calibration curve. Results: The gross radiomic signature (AUC: training set = 0.896; validation set = 0.876) showed a good ability to discriminate infiltration of adenocarcinoma, comparing to intranodular (AUC: training set = 0.862; validation set = 0.852) or perinodular radiomic signature (AUC: training set = 0.825; validation set = 0.820). The AUC of the combined clinical-radiomic model was 0.917 for the training and 0.876 for the validation cohort, respectively. Conclusions: The gross radiomic signature of intranodular and perinodular regions improved the prediction ability and aided predicting the invasiveness of lung adenocarcinoma appearing as GGNs.

29 January 2022 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
CGChen Gao
Chen Gao
NKNing Kong
Ning Kong
FZFan Zhang
Fan Zhang
TTTianyu Tang
Tianyu Tang
JLJiaying Li
Jiaying Li
MXMaosheng Xu
Maosheng Xu
Background: Determining the prognosis of lung adenocarcinoma (LUAD) is challenging. The present study aimed to identify prognostic ferroptosis-related long noncoding RNAs (FRLs) and construct a prognostic model. Moreover, differential analysis of immune and N6-methyladenosine (m6A)-related genes was systematically conducted. Methods: A total of 504 patients selected from a dataset from The Cancer Genome Atlas were included. The patients with LUAD were randomly divided into a training group and a test group at a ratio of 1:1. Pearson correlation analysis and univariate Cox regression analysis were used to identify the prognostic FRLs. Then, a prognostic model was constructed from the optimized subset of prognostic FRLs based on the least absolute shrinkage and selection operator (LASSO) algorithm. Subsequently, the receiver operating characteristic (ROC) curve and survival analysis were used to evaluate the performance of the model. The risk score based on the prognostic model was analyzed using Cox regression analysis. Moreover, gene set enrichment analysis and differential analysis of immune- and m6A-related genes were conducted. Results: After univariate Cox regression analysis and LASSO algorithm analysis, a total of 19 prognostic FRLs were selected to construct the final model to obtain the risk score. The area under the ROC curve of the prognostic model for 1-year, 3-year, and 5-year overall survival (OS) was 0.763, 0.745, and 0.778 in the training set and 0.716, 0.724, and 0.736 in the validation set, respectively. Moreover, the OS of the high-risk group was significantly worse than that of the low-risk group in the training group (P < 0.001) and in the test group (P < 0.001). After univariate and multivariate Cox regression analysis, the risk score [hazard ratio (HR) = 1.734; P < 0.001] and stage (HR = 1.557; P < 0.001) were both considered significant prognostic factors for LUAD. A nomogram was constructed based on clinical features and risk score. The expression of 34 checkpoint genes and 13 m6A-related genes varied significantly between the two risk groups. Conclusion: This study constructed a prognostic model to effectively predict the OS of patients with LUAD, and these OS-related FRLs might serve as potential therapeutic targets of LUAD.

25 February 2025 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
XWXinyu Wu
Xinyu Wu
YXYufei Xia
Yufei Xia
XLXinjing Lou
Xinjing Lou
KHKeling Huang
Keling Huang
LWLinyu Wu
Linyu Wu
CGChen Gao
Chen Gao
Radiomics and AI have been widely used in breast cancer imaging, but a comprehensive systematic analysis is lacking. Therefore, this study aims to conduct a bibliometrics analysis in this field to discuss its research status and frontier hotspots and provide a reference for subsequent research. Publications related to AI, radiomics, and breast cancer imaging were searched in the Web of Science Core Collection. CiteSpace plotted the relevant co-occurrence network according to authors and keywords. VOSviewer and Pajek were used to draw relevant co-occurrence maps according to country and institution. In addition, R was used to conduct bibliometric analysis of relevant authors, countries/regions, journals, keywords, and annual publications and citations based on the collected information. A total of 2,701 Web of Science Core Collection publications were retrieved, including 2,486 articles (92.04%) and 215 reviews (7.96%). The number of publications increased rapidly after 2018. The United States of America (n = 17,762) leads in citations, while China (n = 902) leads in the number of publications. Sun Yat-sen University (n = 75) had the largest number of publications. Bin Zheng (n = 28) was the most published author. Nico Karssemeijer (n = 72.1429) was the author with the highest average citations. “Frontiers in Oncology” was the journal with the most publications, and “Radiology” had the highest IF. The keywords with the most frequent occurrence were “breast cancer”, “deep learning”, and “classification”. The topic trends in recent years were “explainable AI”, “neoadjuvant chemotherapy”, and “lymphovascular invasion”. The application of radiomics and AI in breast cancer imaging has received extensive attention. Future research hotspots may mainly focus on the progress of explainable AI in the technical field and the prediction of lymphovascular invasion and neoadjuvant chemotherapy efficacy in clinical application.

13 January 2024 in European Journal of Radiology
Verified
Journal Article
Open access
LQLujie Qian
Lujie Qian
TWTing Wu
Ting Wu
SKShuaihang Kong
Shuaihang Kong
XLXinjing Lou
Xinjing Lou
YJYixiao Jiang
Yixiao Jiang
CGChen Gao
Chen Gao
To summarize the underlying biological correlation of prognostic radiomics and deep learning signatures in patients with lung cancer and evaluate the quality of available studies. This study examined databases including the PubMed, Embase, Web of Science Core Collection, and Cochrane Library, for studies that elaborated on the underlying biological correlation with prognostic radiomics and deep learning signatures based on CT or PET/CT for predicting the prognosis in patients with lung cancer. Information about the patient and radiogenomic analyses was extracted for the included studies. The Radiomics Quality Score (RQS) and the Prediction Model Risk of Bias Assessment Tool were used to assess the quality of these studies. Twelve studies were included with 7,338 patients from 2014 to 2022. All studies except for one were retrospective. Supervised machine learning was adopted in six studies, and the remaining used unsupervised machine learning methods. Gene sequencing and histopathological data were analyzed by 83.33% and 16.67% of the included studies, respectively. Gene set enrichment analysis and correlation analysis were most used to explore the biological meaning of prognostic signatures. The median RQS for supervised learning articles was 13.5 (range 12-19) and 7.0 (range 5-14) for unsupervised learning articles. The studies included in this report were assessed to have high risk of bias overall. The biological basis for the interpretability of data-driven models mainly focused on genomics and histopathological factors, and it may improve the prognosis of lung cancer with more proper biological interpretation in the future.

9 December 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LWLinyu Wu
Linyu Wu
GCGuoquan Cao
Guoquan Cao
LZLiang Zhao
Liang Zhao
KTKun Tang
Kun Tang
JLJie Lin
Jie Lin
XZXiangwu Zheng
Xiangwu Zheng
Objective. The objective is to assess the value of spatial distribution difference in iodine concentration between malignant and benign solitary pulmonary nodules (SPNs) by analyzing multiple parameters of spectral CT. Methods. Sixty patients with 39 malignant nodules and 21 benign nodules underwent chest contrast CT scans using spectral imaging mode during pulmonary arterial phase (PP), arterial phase (AP), and venous phase (VP). Iodine concentrations of proximal and distal regions in pulmonary nodules on iodine-based material decomposition images were recorded. Normalized iodine concentration (NIC) and the differences in NIC between the proximal and the distal regions (dNIC) were calculated. The two-sample t-test and Mann–Whitney U-test were performed to compare the multiple parameters generated from spectral CT between malignant and benign nodules. Receiver operating characteristic (ROC) curves were generated to calculate sensitivity and specificity. Results. NIC in the proximal region (NICpro) and NIC in the distal region (NICdis) between malignant and benign nodules at AP (NICpro, P=0.012; NICdis, P=0.024), and VP (NICpro, P=0.005; NICdis, P =0.004) were significantly different. NICpro at PP (P = 0.037) was also found significantly different between malignant and benign nodules; however, no significant differences were found in NICdis at PP (P = 0.093). In addition, the dNIC of malignant nodules was significantly higher than that of benign ones at PP (median and interquartiles (0.31, 0.11, 0.57 versus -0.26, -0.5, -0.1); p≤0.001), AP (mean dNIC, 0.093 ±0.094 versus -0.075±0.060; p≤0.001), and VP (mean dNIC, 0.171±0.137 versus -0.183±0.127; p≤0.001). The sensitivity and specificity (93%, 95%, respectively) of dNIC during VP were higher than other parameters, with a threshold value of -0.07. Conclusions. Spectral CT imaging with multiple parameters such as NICpro, NICdis, and dNIC may be a new method for differentiating malignant SPNs from benign ones.

8 August 2022 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
CGChen Gao
Chen Gao
NKNing Kong
Ning Kong
FZFan Zhang
Fan Zhang
LZLiuzhi Zhou
Liuzhi Zhou
MXMaosheng Xu
Maosheng Xu
LWLinyu Wu
Linyu Wu
Background: The treatment and prognosis of lung adenocarcinoma (LUAD) remains a challenge. The study aimed to conduct a systematic analysis of the predictive capacity of N6-methyladenosine (m6A)-related long non-coding RNAs (lncRNAs) in the prognosis of LUAD. Methods: 594 samples were totally selected from a dataset from The Cancer Genome Atlas. The identification of prognostic m6A-related lncRNAs were performed by Pearson correlation analysis and Cox regression analysis. Systematic analyses, including cluster analysis, survival analysis, and immuno-correlated analysis, were conducted. A prognosis model was built from the optimized subset of m6A-related lncRNAs. The assessment of model was performed by survival analysis, and receiver operating characteristic (ROC) curve. Finally, the risk score of patients with LUAD calculated by the prognosis model was implemented by the analysis of Cox regression. Differential analysis was for further evaluation of the cuproptosis-related genes in two risk sets. Results: These patients were grouped into two clusters according to the expression levels of 22 prognostic m6A-related lncRNAs. The patients with LUAD in cluster 2 was significantly worse in the overall survival (OS) (P = 0.006). Three scores calculated by the ESTIMATE methods in cluster 2 were significantly lower. After the least absolute shrinkage and selection operator algorithm, 10 prognostic m6A-related lncRNAs were totally selected to construct the final model to obtain the risk score. Then the area under the ROC curve of the prognosis model for 1, 3, and 5-year OS was 0.767, 0.709, and 0.736 in the training set, and 0.707, 0.691, and 0.675 in the test set. The OS of the low-risk cohort was significantly higher than that of the high-risk cohort in both the training set (P < 0.001) and test set (P < 0.001). After the analysis of Cox regression, the risk score [Hazard ratio (HR) = 5.792; P < 0.001] and stage (HR = 1.576; P < 0.001) were both considered as independent indicators of prognosis for LUAD. The expression levels of five cuproptosis-related genes were significantly different in two risk sets. Conclusions: The study constructed a predictive model for the OS of patients with LUAD and these OS-related m6A-lncRNAs might have potential roles in LUAD progression.